Grant: Discovery Grants Program - Individual
University of Alberta
$30,000.00
Cross-kingdom platforms to study bacterial ubiquitin ligases in eukaryotic cells
FY 2022-23
Summary
My research program aims to understand how bacterial ubiquitin ligase (BUL) proteins, produced and delivered by bacteria, alter the biology of eukaryotic cells. BULs can covalently link ubiquitin, a small 76-amino acid eukaryotic protein, to a substrate protein. The number and structure of linked ubiquitin moieties can modify substrate function, or cause its degradation. Substrate degradation, and a lack of molecular tools and probes, pose a challenge to understanding BUL functions in the host. We are using new insights gained from three diverse, and complementary eukaryotic platforms to make comprehensive models of BUL functions in eukaryotes. Platform 1. Mechanistic study of Salmonella enterica BUL function in mammalian cells. We are introducing bacterial ubiquitin ligases into mammalian cells using reliable plasmid-based expression systems or bacterial delivery. Using this approach we are examining whether the pattern recognition receptors (PRR), NOD2 and NLRP3, are substrates of the S. enterica BUL, SspH2. We will isolate complexes of SspH2 and interacting host proteins, the latter of which will be identified by mass spectrometry or antibody detection. We will also use mass spectrometry to identify specific PRR residues that are ubiquitinated by SspH2. We will subsequently mutate these residues to determine if ubiquitin transfer plays a role in innate immune subversion by SspH2. Platform 2. Using yeast to develop tools to study BUL function. Yeast have long-served as a model to explore the cellular activity of bacterial effectors because it is genetically tractable and the potential to translate discoveries to mammalian systems is high. We have shown that the S. enterica BUL, SspH1, exerts profound toxicity in yeast. We are using robust screening tools available in this platform to develop reagents that inhibit SspH1 function. We have identified two substrate variants that suppress SspH1 toxicity and will use them to probe potential defects in cell morphology and cell cycle progression. This platform is also amenable to small molecule screening. Platform 3. Examining S. enterica BUL-plant immunity interactions. Plants are an emerging host for S. enterica with increasing reports of S. enterica-contaminated produce. Plants possess immune responses that can be subverted by S. enterica Type 3 secretion system effectors. I have developed systems to introduce S. enterica BULs into tobacco and found that SspH2 enhanced an immune-like response in planta. In this platform we will use mass spectrometry to identify plant protein substrates of SspH2. We will also examine immune responses via gene expression and functional assays to determine how SspH2 subverts plant immunity. Together these platforms are a useful array of model systems and resources, with which to gain a fulsome understanding of how BULs function in host cells. This knowledge will shed new light on host-pathogen interactions that could be exploited for targeted disruption.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-04359
Name nom
Bhavsar, Amit
Department département
Medical Microbiology and Immunology - Medical Microbiology and Immunology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2020
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Installment
inst:3
Partie
1
Nb partie
5
Application title
Cross-kingdom platforms to study bacterial ubiquitin ligases in eukaryotic cells
Application summary
My research program aims to understand how bacterial ubiquitin ligase (BUL) proteins, produced and delivered by bacteria, alter the biology of eukaryotic cells. BULs can covalently link ubiquitin, a small 76-amino acid eukaryotic protein, to a substrate protein. The number and structure of linked ubiquitin moieties can modify substrate function, or cause its degradation. Substrate degradation, and a lack of molecular tools and probes, pose a challenge to understanding BUL functions in the host. We are using new insights gained from three diverse, and complementary eukaryotic platforms to make comprehensive models of BUL functions in eukaryotes. Platform 1. Mechanistic study of Salmonella enterica BUL function in mammalian cells. We are introducing bacterial ubiquitin ligases into mammalian cells using reliable plasmid-based expression systems or bacterial delivery. Using this approach we are examining whether the pattern recognition receptors (PRR), NOD2 and NLRP3, are substrates of the S. enterica BUL, SspH2. We will isolate complexes of SspH2 and interacting host proteins, the latter of which will be identified by mass spectrometry or antibody detection. We will also use mass spectrometry to identify specific PRR residues that are ubiquitinated by SspH2. We will subsequently mutate these residues to determine if ubiquitin transfer plays a role in innate immune subversion by SspH2. Platform 2. Using yeast to develop tools to study BUL function. Yeast have long-served as a model to explore the cellular activity of bacterial effectors because it is genetically tractable and the potential to translate discoveries to mammalian systems is high. We have shown that the S. enterica BUL, SspH1, exerts profound toxicity in yeast. We are using robust screening tools available in this platform to develop reagents that inhibit SspH1 function. We have identified two substrate variants that suppress SspH1 toxicity and will use them to probe potential defects in cell morphology and cell cycle progression. This platform is also amenable to small molecule screening. Platform 3. Examining S. enterica BUL-plant immunity interactions. Plants are an emerging host for S. enterica with increasing reports of S. enterica-contaminated produce. Plants possess immune responses that can be subverted by S. enterica Type 3 secretion system effectors. I have developed systems to introduce S. enterica BULs into tobacco and found that SspH2 enhanced an immune-like response in planta. In this platform we will use mass spectrometry to identify plant protein substrates of SspH2. We will also examine immune responses via gene expression and functional assays to determine how SspH2 subverts plant immunity. Together these platforms are a useful array of model systems and resources, with which to gain a fulsome understanding of how BULs function in host cells. This knowledge will shed new light on host-pathogen interactions that could be exploited for targeted disruption.